본문 바로가기

Comparison of Amyloid in Cerebrospinal Fluid, Brain Imaging, and Autopsy in a Case of Progressive Supranuclear Palsy

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2Scopus Q1
저널
ALZHEIMER DISEASE & ASSOCIATED DISORDERS34(3) · pp.275 · 2020
피인용
Web of Science 2Scopus 2
FWCI (Scopus)
0
JCR IF
JCR 2019 2.098
ISSN
0893-0341

저자

  1. 김경혜제1저자Departments of ∗ Neurology
  2. 서재득Departments of ∗ Neurology
  3. 김은수Anesthesia and Pain Medicine
  4. 김향숙Research Institute for Convergence of Biomedical Science and Technology
  5. 전수민Departments of ∗ Neurology
  6. 박경준Nuclear Medicine
  7. 이명준Departments of ∗ Neurology
  8. 이재혁Department of Neurology Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital
  9. 이영민Psychiatry
  10. 이강윤Psychiatry
  11. 신진홍Department of Neurology Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital
  12. 고준경# Neurosurgery
  13. 정나연Department of Neurology Research Institute for Convergence of Biomedical Science and Technology Pusan National University Yangsan Hospital
  14. 이재민# Neurosurgery
  15. 윤진아Rehabilitation Medicine Pusan National University Hospital Pusan National University School of Medicine and Biomedical Research Institute Busan
  16. 황청수Departments of †† Pathology
  17. 안재우Departments of †† Pathology
  18. 성석‡‡ Anatomy
  19. Spina, Salvatore§§ Department of Neurology Memory and Aging Center University of California San Francisco CA
  20. Seeley, William W.§§ Department of Neurology Memory and Aging Center University of California San Francisco CA
  21. 최경운Departments of †† Pathology
  22. 허기영∥∥ Forensic Medicine Pusan National University School of Medicine Yangsan Republic of Korea
  23. 김은주교신저자Departments of ∗ Neurology

초록

Cerebrospinal fluid (CSF) amyloid-beta 1-42 (A beta(1-42)) and amyloid positron emission tomography (PET) are the 2 main Alzheimer disease amyloid biomarkers that have been validated in neuropathologically confirmed Alzheimer disease cases. Although many studies have shown concordance of amyloid positivity or negativity between CSF A beta(1-42)and amyloid PET, several studies also reported discrepancies between these 2 A beta biomarkers. We conducted a comparison of CSF A beta(1-42)level, amyloid PET, and autopsy findings in a case with progressive supranuclear palsy in which biomarker acquisition and postmortem pathologic examination were conducted almost at the same time. Our case with antemortem CSF A beta(1-42)(+)/amyloid PET (-) who was pathologically confirmed with A beta pathology in the cerebral cortex may indicate CSF A beta(1-42)is more sensitive for assessing in vivo A beta than amyloid PET.

키워드

cerebrospinal fluid amyloid-betaamyloid positron emission tomographyautopsyALZHEIMERSBETA

식별자

Scopus EID
2-s2.0-85089811293
WoS UID
000570206400015